Signal active
Organization
Contact Information
Overview
N/A
About
Biotechnology, Genetics, Clinical Trials
2021
11-50
Headquarters locations
Asia
Social
N/A
Profile Resume
GenEditBio headquartered in Asia, operates in the Biotechnology, Genetics, Clinical Trials sector. The company focuses on Biotechnology and has secured $120.0M in funding across 12 round(s). With a team of 11-50 employees, GenEditBio is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - GenEditBio, raised $10.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
1
5
0
$10.0M
Details
1
GenEditBio has raised a total of $10.0M in funding over 1 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2024 | Seed | 10.0M |
Investors
GenEditBio is funded by 9 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
GenEditBio | - | FUNDING ROUND - GenEditBio | 10.0M |
Hong Kong Science and Technology Parks Corporation | - | FUNDING ROUND - Hong Kong Science and Technology Parks Corporation | 10.0M |
GenEditBio | - | FUNDING ROUND - GenEditBio | 10.0M |
Shuntian Pharmaceuticals | - | FUNDING ROUND - Shuntian Pharmaceuticals | 10.0M |
Recent Activity
There is no recent news or activity for this profile.